1. Home
  2. FSSL vs INMD Comparison

FSSL vs INMD Comparison

Compare FSSL & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Specialty

FSSL

FS Specialty

N/A

Current Price

$11.80

Market Cap

906.5M

Sector

Finance

ML Signal

N/A

Logo InMode Ltd.

INMD

InMode Ltd.

N/A

Current Price

$14.05

Market Cap

857.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSSL
INMD
Founded
2010
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.5M
857.4M
IPO Year
2025
2018

Fundamental Metrics

Financial Performance
Metric
FSSL
INMD
Price
$11.80
$14.05
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
★ $16.17
AVG Volume (30 Days)
224.0K
★ 396.6K
Earning Date
01-01-0001
11-04-2026
Dividend Yield
★ 15.05%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$2.30
P/E Ratio
★ $9.70
$10.11
Revenue Growth
N/A
N/A
52 Week Low
$10.75
$12.72
52 Week High
$14.49
$16.74

Technical Indicators

Market Signals
Indicator
FSSL
INMD
Relative Strength Index (RSI) 51.34 29.97
Support Level $11.43 $13.27
Resistance Level $11.90 $14.18
Average True Range (ATR) 0.24 0.18
MACD -0.03 -0.03
Stochastic Oscillator 47.47 4.44

Price Performance

Historical Comparison
FSSL
INMD

About FSSL FS Specialty

FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing mainly in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest mainly in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.

About INMD InMode Ltd.

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.

Share on Social Networks: